1. Kurmani, S & Squire, I (2017) Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep 14, 385–392.
2. Ponikowski, P, Voors, AA, Anker, SD, et al. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18, 891–975.
3. Lloyd-Jones, DM, Larson, MG, Leip, EP, et al. (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106, 3068–3072.
4. Horowitz, JD & Kennedy, JA (2006) Time to address the cardiac metabolic ‘triple whammy’ ischemic heart failure in diabetic patients. J Am Coll Cardiol 48, 2232–2234.
5. Maack, C & Bohm, M (2011) Targeting mitochondrial oxidative stress in heart failure throttling the afterburner. J Am Coll Cardiol 58, 83–86.
6. Diaz-Velez, CR, Garcia-Castineiras, S, Mendoza-Ramos, E, et al. (1996) Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 131, 146–152.
7. Aukrust, P, Yndestad, A, Damas, JK, et al. (2004) Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin. Autoimmun Rev 3, 221–227.
8. Cenac, A, Simonoff, M & Djibo, A (1996) Nutritional status and plasma trace elements in peripartum cardiomyopathy. A comparative study in Niger. J Cardiovasc Risk 3, 483–487.
9. Kosar, F, Sahin, I, Taskapan, C, et al. (2006) Trace element status (Se, Zn, Cu) in heart failure. Anadolu Kardiyol Derg 6, 216–220.
10. Ghaemian, A, Salehifar, E, Shiraj, H, et al. (2012) A comparison of selenium concentrations between congestive heart failure patients and healthy volunteers. J Tehran Heart Cent 7, 53–57.
11. Ge, K & Yang, G (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 57, 259S–263S.
12. Rees, K, Hartley, L, Day, C, et al. (2013) Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev, issue 1, CD009671.
13. Lippman, SM, Klein, EA, Goodman, PJ, et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51.
14. de Lorgeril, M, Salen, P, Accominotti, M, et al. (2001) Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 3, 661–669.
15. de Lorgeril, M & Salen, P (2006) Selenium and antioxidant defenses as major mediators in the development of chronic heart failure. Heart Fail Rev 11, 13–17.
16. Farrokhian, A, Bahmani, F, Taghizadeh, M, et al. (2016) Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary heart disease. Horm Metab Res 48, 263–268.
17. Ju, W, Li, X, Li, Z, et al. (2017) The effect of selenium supplementation on coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. J Trace Elem Med Biol 44, 8–16.
18. Tabrizi, R, Akbari, M, Moosazadeh, M, et al. (2017) The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res 49, 826–830.
19. Dickstein, K, Cohen-Solal, A, Filippatos, G, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10, 933–989.
20. Mansournia, MA, Hernan, MA & Greenland, S (2013) Matched designs and causal diagrams. Int J Epidemiol 42, 860–869.
21. Azar, M & Sarkisian, E (1980) Food Composition Table of Iran. Tehran: National Nutrition and Food Research Institute, Shaheed Beheshti University.
22. Pisprasert, V, Ingram, KH, Lopez-Davila, MF, et al. (2013) Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 36, 845–853.
23. Tatsch, E, Bochi, GV, Pereira Rda, S, et al. (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44, 348–350.
24. Benzie, IF & Strain, JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 239, 70–76.
25. Beutler, E & Gelbart, T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105, 581–584.
26. Janero, DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9, 515–540.
27. Bahmani, F, Kia, M, Soleimani, A, et al. (2016) Effect of selenium supplementation on glycemic control and lipid profiles in patients with diabetic nephropathy. Biol Trace Elem Res 172, 282–289.
28. Mansournia, MA & Altman, DG (2018) Invited commentary: methodological issues in the design and analysis of randomised trials. Br J Sports Med 52, 553–555.
29. Mansournia, MA, Higgins, JP, Sterne, JA, et al. (2017) Biases in randomized trials: a conversation between trialists and epidemiologists. Epidemiology 28, 54–59.
30. Greenland, S & Mansournia, MA (2015) Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness. Eur J Epidemiol 30, 1101–1110.
31. Stranges, S, Marshall, JR, Natarajan, R, et al. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147, 217–223.
32. Galan–Chilet, I, Grau-Perez, M, De Marco, G, et al. (2017) A gene–environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study. Redox Biol 12, 798–805.
33. Laclaustra, M, Navas-Acien, A, Stranges, S, et al. (2009) Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ Health Perspect 117, 1409–1413.
34. Cold, F, Winther, KH, Pastor-Barriuso, R, et al. (2015) Randomised controlled trial of the effect of long-term selenium supplementation on plasma cholesterol in an elderly Danish population. Br J Nutr 114, 1807–1818.
35. Boskabadi, H, Maamouri, G, Rezagholizade Omran, F, et al. (2012) Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatr Neonatol 53, 334–339.
36. Safaralizadeh, R, Kardar, GA, Pourpak, Z, et al. (2005) Serum concentration of selenium in healthy individuals living in Tehran. Nutr J 4, 32.
37. Rafraf, M, Mahdavi, R & Rashidi, MR (2008) Serum selenium levels in healthy women in Tabriz, Iran. Food Nutr Bull 29, 83–86.
38. Rayman, MP (2008) Food-chain selenium and human health: emphasis on intake. Br J Nutr 100, 254–268.
39. Gao, H, Hagg, S, Sjogren, P, et al. (2014) Serum selenium in relation to measures of glucose metabolism and incidence of type 2 diabetes in an older Swedish population. Diabet Med 31, 787–793.
40. Wei, J, Zeng, C, Gong, QY, et al. (2015) The association between dietary selenium intake and diabetes: a cross-sectional study among middle-aged and older adults. Nutr J 14, 18.
41. Zhou, J, Huang, K & Lei, XG (2013) Selenium and diabetes – evidence from animal studies. Free Radic Biol Med 65, 1548–1556.
42. Alizadeh, M, Safaeiyan, A, Ostadrahimi, A, et al. (2012) Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab 60, 157–168.
43. Kaur, HD & Bansal, MP (2009) Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation. Lipids Health Dis 8, 55.
44. Kuboki, K, Jiang, ZY, Takahara, N, et al. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation 101, 676–681.
45. van Herpen, NA & Schrauwen-Hinderling, VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94, 231–241.
46. Li, YB, Han, JY, Jiang, W, et al. (2011) Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Mol Biol Rep 38, 2301–2306.
47. Brigelius-Flohe, R, Banning, A, Kny, M, et al. (2004) Redox events in interleukin-1 signaling. Arch Biochem Biophys 423, 66–73.
48. Alehagen, U, Lindahl, TL, Aaseth, J, et al. (2015) Levels of sP-selectin and hs-CRP decrease with dietary intervention with selenium and coenzyme Q10 combined: a secondary analysis of a randomized clinical trial. PLOS ONE 10, e0137680.
49. Vunta, H, Davis, F, Palempalli, UD, et al. (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282, 17964–17973.
50. Vunta, H, Belda, BJ, Arner, RJ, et al. (2008) Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52, 1316–1323.
51. Brodska, H, Valenta, J, Malickova, K, et al. (2015) Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium. J Trace Elem Med Biol 31, 25–32.
52. Zhu, X & Lu, Y (2012) Selenium supplementation can slow the development of naphthalene cataract. Curr Eye Res 37, 163–169.
53. Gullestad, L & Aukrust, P (2005) Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 95, 17C–23C.
54. Amir, O, Paz, H, Rogowski, O, et al. (2009) Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients. Clin Cardiol 32, 199–203.
55. Bleys, J, Navas-Acien, A & Guallar, E (2008) Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 168, 404–410.
56. Akbaraly, NT, Arnaud, J, Hininger-Favier, I, et al. (2005) Selenium and mortality in the elderly: results from the EVA study. Clin Chem 51, 2117–2123.
57. Ray, AL, Semba, RD, Walston, J, et al. (2006) Low serum selenium and total carotenoids predict mortality among older women living in the community: the women’s health and aging studies. J Nutr 136, 172–176.